Stock Earnings

Question 1

What are MoonLake Immunotherapeutics's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), MoonLake Immunotherapeutics has a total asset of $0, Net loss of $-227

Question 2

What are the key financial ratios for MLTX?

Accepted Answer

MoonLake Immunotherapeutics's Current ratio is 0, has a Net margin is 0, sales per share of $0.

Question 3

How is MoonLake Immunotherapeutics's revenue broken down by segment or geography?

Accepted Answer

MoonLake Immunotherapeutics largest revenue segment is Ribonucleic Acid Therapeutics, at a revenue of 42,353,702 in the most earnings release.For geography, United Kingdom is the primary market for MoonLake Immunotherapeutics, at a revenue of 42,212,712.

Question 4

Is MoonLake Immunotherapeutics profitable?

Accepted Answer

no, according to the latest financial statements, MoonLake Immunotherapeutics has a net loss of $-227

Question 5

Does MoonLake Immunotherapeutics have any liabilities?

Accepted Answer

no, MoonLake Immunotherapeutics has liability of 0

Question 6

How many outstanding shares for MoonLake Immunotherapeutics?

Accepted Answer

MoonLake Immunotherapeutics has a total outstanding shares of 0

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	41	41	30	22	23	18
Research & Development	202	202	112	31	42	35
Operating Expenses	244	244	143	54	65	53
Other Non Operating Income (Expenses)	22	22	22	10	0	0
Pretax Income	-229	-229	-120	-43	-64	-53
Income Tax Expense	0	0	0	0	0	0
Net Income	-227	-227	-118	-36	-49	-53
Net Income Growth	92%	92%	227.99%	-27%	-8%	--
Shares Outstanding (Diluted)	67.96	64.46	62.87	49.12	29.36	36.93
Shares Change (YoY)	8%	3%	28%	67%	-21%	--
EPS (Diluted)	-3.34	-3.52	-1.89	-0.73	-1.7	-1.45
EPS Growth	77%	86%	158%	-56.99%	17%	--
Free Cash Flow	-196	-196	-117	-43	-55	-35
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-242	-242	-142	-54	-65	-53
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	2	2	1	0	0	0
EBIT	-244	-244	-143	-54	-65	-53
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

MoonLake Immunotherapeutics (MLTX) Financial

MLTX Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is MLTX?

MLTX Income

Follow-Up Questions